Showing results (21-30 of 109) with videos related to
Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|December 18, 2014
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockadeEvan J Lipson, Victor E Velculescu, Theresa S Pritchard, et al.Transplantation Direct|January 25, 2021
Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor AdministrationLaila Lakhani, Sami Alasfar, Anshul Bhalla, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 15, 2025
Beyond Checkpoint Inhibition: Keeping Therapeutic Options OpenUrvashi Mitbander Joshi, Jasmin Hundal, Jonaphine R Mata, et al.Journal of Gastrointestinal Cancer|September 14, 2011
Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literatureJatinder Goyal, Evan J Lipson, Neda Rezaee, et al.Journal for Immunotherapy of Cancer|July 10, 2019
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case seriesJaclyn LoPiccolo, Megan D Schollenberger, Sumia Dakhil, et al.Journal for Immunotherapy of Cancer|March 28, 2017
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockadeEvan J Lipson, Mohammed T Lilo, Aleksandra Ogurtsova, et al.Microbiology Spectrum|February 3, 2025
Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory studyYujie Zhao, Jacqueline T Ferri, James R White, et al.International Journal of Cancer|June 26, 2016
BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasisRussell Maxwell, Tomas Garzon-Muvdi, Evan J Lipson, et al.NPJ Precision Oncology|February 21, 2025
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostatErin E Resch, Stavriani C Makri, Paola Ghanem, et al.Seminars in Arthritis and Rheumatism|March 26, 2018
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimenLaura C Cappelli, Julie R Brahmer, Patrick M Forde, et al.Pageof 11